The Claim
β-casomorphin-7 at physiologically relevant concentrations (4–120 µM) exhibits minimal translocation across the intestinal epithelial barrier in vitro, with the majority of the peptide being degraded by dipeptidyl peptidase-4, resulting in limited systemic exposure.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When β-casomorphin-7 is present at concentrations found in the human gut, it does not pass significantly through the intestinal lining and is mostly broken down by the enzyme dipeptidyl peptidase-4, leading to little entry into the bloodstream.
See the scientific wording
β-casomorphin-7 at physiologically relevant concentrations (4–120 µM) shows minimal translocation across the intestinal epithelial barrier in vitro, with most peptide likely degraded by dipeptidyl peptidase-4, suggesting limited systemic exposure.
When β-casomorphin-7 enters the gut, an enzyme called dipeptidyl peptidase-4 cuts it into smaller pieces before it can pass through the intestinal wall, so very little of it reaches the bloodstream.
What the research says
1 studyWhen you drink A1 milk, a small piece of protein called BCM-7 is made, but your gut breaks it down quickly before it can get into your blood — and this study shows that’s exactly what happens.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.